Signalling molecule
Interleukin-11
A signalling molecule whose activity can be blocked
Hypotheses on this target 5
Lower level
Synthesis suppression
Neutralisation3
Supplementation
Accelerated excretion
Neutralisation3
Interleukin-11 blockade may change displayed self-peptides and trigger immune injury
Where this hypothesis actsProspectively specified susceptible epithelia in aging humans
What is proposedBlock IL-11 activity
With whatNot stated in the record
HowOrthogonal epithelial IL-11 perturbations; specific agents are not stated in the record
Possible resultPossible altered self-peptide display and antigen-specific injury that offsets an independently demonstrated benefit
2026-10-10
Blocking interleukin-11 may free shared receptors to sustain harmful competing signals
Where this hypothesis actsA subset of aging-human cells with a shared, functionally limiting surface gp130 pool
What is proposedSuppress IL-11 activity while testing whether blockade releases receptor-bound gp130
With whatNot stated in the record
HowCompare occupancy-releasing and occupancy-retaining blocker modalities at comparable IL-11 inhibition
Possible resultPossible increased competing signaling and sustained functional harm despite IL-11 suppression
2026-10-10
Interleukin-11 may reflect injury while exerting little control over human aging
Where this hypothesis actsOrdinary human aging, within specified tissues, exposures and durations
What is proposedSuppress IL-11-mediated signalling
With whatNot stated in the record
HowIL-11 blockade; the record does not specify a blocking agent or delivery method
Possible resultPossible pathway suppression without substantial slowing of aging or consequential repair or infection costs
2026-10-10